Michael Vasconcelles
Director; Head of Research and Dev. · 2 filings · Latest: Jun 4, 2026
Day One Biopharmaceuticals, Inc.
Kura Oncology, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
DAWN | Michael Vasconcelles | Head of Research and Dev. | Apr 23, 2026 | Disposition | — | 4,397 | — | 0 |